Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Anti-alpha4/beta7 [A4B7R1]

Product Type: Therapeutics (In Vivo)
Format: Anti-alpha-4/beta-7 integrin, humanized VR, rhesus IgG1LAGA Fc
Clone ID: [A4B7R1]
RRID: AB_2716326
Common Names: Anti-alpha4/beta7 [A4B7R1] | Anti-alpha-4/beta-7 integrin | pACT1 | vedolizumab | Anti-Alpha-4/beta-7 | PR-1427 | NHP16
Target: alpha4/beta7
Reactivity: Rhesus Macaque (Macaca mulatta) Human (Homo sapiens) Human Rhesus
Applications: in vivo
Description:

A4B7R1LAGA: Rhesus recombinant, humanized anti-alpha4beta7, effector-silenced IgG1-kappa antibody. Derived from vedolizumab.

 

How to cite this reagent:

The rhesus IgG1 recombinant Anti-alpha4/beta7 [A4B7R1] monoclonal antibody was engineered with 'LAGA' mutations and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-1427, RRID:AB_2716326)

Modifications: None
Restrictions: No
Sponsor: NIAID
How to cite (Methods): "The rhesus IgG1 recombinant Anti-alpha4/beta7 [A4B7R1] monoclonal antibody was engineered with 'LAGA' mutations and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-1427, RRID:AB_2716326)."
How to cite (Acknowledgments): "The Anti-alpha4/beta7 [A4B7R1] antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (U24 AI126683)"

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.